Jeff Frelick, Chief Executive Officer at Bone Biologics Corp (BBLG), bought 9,500 shares at $0.69 ($7K) on 2023-09-11, disclosed to the SEC on 2023-09-12.
Open-market purchase of $7k BBLG by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.